Reported covered position: Sen Harry Reid, Leg Dir; Rep Steny Hoyer, Sr Leg, Asst; Sen Charles Schumer, Dir Econ Dev&Approp
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Drug Safety Enhancement Act of 2011
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · third_quarter · Q3
Medicare drug reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · third_quarter · Q3
Source: Senate LDA
| ELI LILLY AND COMPANY |
| 2 |
| 2012 |
| GILEAD SCIENCES, INC. | 2 | 2012 |
| MCNEIL CONSUMER HEALTHCARE LLC | 2 | 2012 |
| OREXIGEN THERAPEUTICS, INC. | 2 | 2012 |
| SANOFI US SERVICES INC | 2 | 2012 |
| TELADOC INC | 2 | 2012 |
| SUSAN G KOMEN FOR THE CURE | 1 | 2012 |
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011ug User Fee Act.
Drug Safety Enhancement Act of 2011
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Medicare Orthotics and Prosthetics Improvement Act of 2011
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.
Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: CHIMERIX, INC. · Firm: FOLEY HOAG LLP
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations).
H.R. 3497, the MODDERN Cures Act.
S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescription Drug User Fee Act Amendments.
S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescription Drug User Fee Act Amendments.
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.
Improving Nutrition for America's Children Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.
Improving Nutrition for America's Children Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.
Medicare drug reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · third_quarter · Q3
Medicare drug reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIMERIX, INC. via FOLEY HOAG LLP
2012 · third_quarter · Q3
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECTRUM PHARMACEUTICALS via FOLEY HOAG LLP
2012 · third_quarter · Q3
Medicare payment for Part B drugs and biologics.
Regulation of radiolabeled medical products. Drug shortages for oncology products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Q3
Issues Related to FDA regulation of needle-free jet administration of vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREXIGEN THERAPEUTICS, INC. via FOLEY HOAG LLP
2012 · third_quarter · Q3
Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the regulation of novel therapeutics for the treatment of obesity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · third_quarter · Q3
Medicare drug reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2012 · third_quarter · Q3
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2012 · third_quarter · Q3
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2012 · third_quarter · Q3
S.3187, Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2012 · third_quarter · Q3
H.R. 3497, the MODDERN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2012 · third_quarter · Q3
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2012 · third_quarter · Q3
S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · second_quarter · Q2
Medicare drug reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · second_quarter · Q2
Medicare drug reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Q2
Issues Related to FDA regulation of needle-free jet administration of vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TELADOC INC via FOLEY HOAG LLP
2012 · second_quarter · Q2
S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescription Drug User Fee Act Amendments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2012 · second_quarter · Q2
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
Budget Control Act of 2011 (P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SPECTRUM PHARMACEUTICALS via FOLEY HOAG LLP
2012 · second_quarter · Q2
Medicare payment for Part B drugs and biologics.
Regulation of radiolabeled medical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Q2
Issues Related to FDA regulation of needle-free jet administration of vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREXIGEN THERAPEUTICS, INC. via FOLEY HOAG LLP
2012 · second_quarter · Q2
Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the regulation of novel therapeutics for the treatment of obesity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIMERIX, INC. via FOLEY HOAG LLP
2012 · second_quarter · Q2
Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2012 · second_quarter · Q2
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC via FOLEY HOAG LLP
2012 · second_quarter · Q2
Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2012 · second_quarter · Q2
FDA legislation and regulatory implementation issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2012 · second_quarter · Q2
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011ug User Fee Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION via FOLEY HOAG LLP
2012 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2012 · second_quarter · Q2
FDA legislation and regulatory implementation issues. Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · second_quarter · RA
Medicare drug reimbursement.
SPECTRUM PHARMACEUTICALS via FOLEY HOAG LLP
2012 · second_quarter · RA
Medicare payment for Part B drugs and biologics Regulation of radiolabeled medical products
Medicare payment for Part B drugs and biologics Regulation of radiolabeled medical products
OPTIMER PHARMACEUTICALS, INC. via FOLEY HOAG LLP
2012 · second_quarter · RR
Medicare drug reimbursement.
TELADOC INC via FOLEY HOAG LLP
2012 · second_quarter · RR
S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescription Drug User Fee Act Amendments.